Skip to Main Content
Table 2

Antimicrobial susceptibilities of Elizabethkingia isolate determined by MIC strips

Antimicrobial agentMIC (μg/mL)Interpretation
Ciprofloxacin 0.25 
Amicacin >256 
Amoxicillin >256 
Trimethoprim-sulfamethoxazole 0.25 
Gentamicin >256 
Aztreonam >64 
Ceftazidime >256 
Tobramycin >256 
Amoxicillin-clavulanic acid >256 
Piperacillin-Tazobactam 
Meropenem >32 
Imipenem >32 
Colistin >256 
Tigercyclin 0.25 
Vancomycin 
Antimicrobial agentMIC (μg/mL)Interpretation
Ciprofloxacin 0.25 
Amicacin >256 
Amoxicillin >256 
Trimethoprim-sulfamethoxazole 0.25 
Gentamicin >256 
Aztreonam >64 
Ceftazidime >256 
Tobramycin >256 
Amoxicillin-clavulanic acid >256 
Piperacillin-Tazobactam 
Meropenem >32 
Imipenem >32 
Colistin >256 
Tigercyclin 0.25 
Vancomycin 

Submitted isolate to Genbank (accession no. MF615392). The results were interpreted according to the recommendations of the European Committee on Antimicrobial Susceptibility Testing, version 7.1. for Staphylococcus spp. (vancomycin) and Pseudomonas aeruginosa (other antibiotics except for co-trimoxazole in which Stenotrophomonas maltophilia breakpoints were used), since there are no criteria for Elizabethkingia.

Close Modal

or Create an Account

Close Modal
Close Modal